LMT vs TERN · P/E 20, rev $75.05B vs $6.12B cap
Lockheed Martin Corporation (LMT) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Lockheed Martin Corporation (LMT) is a aerospace & defense company listed on US. It is led by Jim Taiclet.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported LMT revenue for 2025-12-31 was $75.05B. Net income was $5.02B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. LMT currently screens at market cap $108.37B and trailing P/E 19.9.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
LMT currently screens at market cap $108.37B and trailing P/E 19.9. TERN currently screens at market cap $6.12B.
Not investment advice. Open the LMT and TERN stock pages for the full models.
Not investment advice.